- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AZN
Recent news which mentions AZN
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
August 29, 2023
From Benzinga
Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government
August 25, 2023
From Benzinga
Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases
August 25, 2023
From InvestorPlace
As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list
August 25, 2023
From MarketWatch
From Benzinga
From Benzinga
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
From InvestorPlace
From Benzinga
Pfizer maternal RSV vaccine gets FDA approval
August 21, 2023
From MarketWatch
The 3 Most Undervalued Pharma Stocks to Buy Now: August 2023
August 21, 2023
From InvestorPlace
Cheaper Alternatives of Weight-Loss Drugs? Chinese Pharma Companies Are Working On a Local Version
August 16, 2023
From Benzinga
Is This Blue Chip Dividend Stock a Buy for Growth Investors?
August 08, 2023
Tickers
AZN
From Motley Fool
From Benzinga
3 Pharma Stocks to Buy for Their Promising Progress
July 31, 2023
From InvestorPlace
AstraZeneca Abandons Blood Cancer, Cardiovascular Programs Amid Portfolio Prioritization
July 28, 2023
From Benzinga
From MarketWatch
From Benzinga
AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots Up
July 28, 2023
From Benzinga
US Stock Futures Signal Rebound On Tech Earnings Support: Analyst Tells Why Fed May Not Start Cutting Rates Anytime Soon
July 28, 2023
From Benzinga
Earnings Scheduled For July 28, 2023
July 28, 2023
From Benzinga
Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports
July 26, 2023
From Benzinga
Dow Jones Leads Weekly Gains As Tesla, Netflix Sell-Offs Dent Nasdaq; Big Banks Show Resilience To Volatility
July 21, 2023
From Benzinga
Why Pieris Pharmaceuticals Shares Shooting Higher Today?
July 18, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.